Insider trading

Period: 120 months Stock: DGX Plan: Not stated × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

121 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

121 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

121 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

121 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
121 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
121 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

121 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
7 Mar 2023
Doherty Catherine T. SVP, Regional Businesses
Sold, plan not stated
$745.90K 5,307 at 140.55
7.3%
7 Mar 2023
PREVOZNIK MICHAEL E SVP & General Counsel
Sold, plan not stated
$668.17K 4,754 at 140.55
11.0%
3 Mar 2023
Doherty Catherine T. SVP, Regional Businesses
Sold, plan not stated
$100.83K 717 at 140.63
1.0%
2 Mar 2023
PREVOZNIK MICHAEL E SVP & General Counsel
Sold, plan not stated
$82.15K 593 at 138.54
1.5%
24 Feb 2023
Doherty Catherine T. SVP, Regional Businesses
Sold, plan not stated
$239.00K 1,690 at 141.42
2.4%
24 Feb 2023
PREVOZNIK MICHAEL E SVP & General Counsel
Sold, plan not stated
$200.11K 1,415 at 141.42
3.5%
1 Dec 2022
RING TIMOTHY M Director
Sold, plan not stated
$308.81K 2,025 at 152.50
7.7%
28 Nov 2022
Doherty Catherine T. SVP, Regional Businesses
Sold, plan not stated 2×
$6.08M 40,765 at 149.18
37.6%
1 Nov 2022
RING TIMOTHY M Director
Sold, plan not stated
$288.12K 2,000 at 144.06
7.6%
26 Oct 2022
Deppe Michael J VP, Corp. Controller & CAO
Sold, plan not stated
$2.25M 15,497 at 145.00
32.6%
3 Oct 2022
RING TIMOTHY M Director
Sold, plan not stated
$246.78K 2,000 at 123.39
7.7%
1 Sep 2022
RING TIMOTHY M Director
Sold, plan not stated
$250.04K 2,000 at 125.02
7.7%
1 Aug 2022
RING TIMOTHY M Director
Sold, plan not stated
$272.08K 2,000 at 136.04
7.7%
1 Jul 2022
RING TIMOTHY M Director
Sold, plan not stated
$266.94K 2,000 at 133.47
7.7%
25 May 2022
RUSCKOWSKI STEPHEN H Chairman, CEO and President
Sold, plan not stated 6×
$3.51M 24,891 at 140.89
6.9%
24 May 2022
RUSCKOWSKI STEPHEN H Chairman, CEO and President
Sold, plan not stated 2×
$39.57M 282,408 at 140.12
45.8%
23 May 2022
RUSCKOWSKI STEPHEN H Chairman, CEO and President
Sold, plan not stated 6×
$10.86M 77,466 at 140.17
18.8%
17 May 2022
PREVOZNIK MICHAEL E SVP & General Counsel
Sold, plan not stated
$7.08M 50,604 at 139.97
56.3%
Sold half or more
8 Mar 2022
Doherty Catherine T. SVP, Group Exec. Clin. Fran.
Sold, plan not stated
$950.80K 7,032 at 135.21
9.4%
8 Mar 2022
PREVOZNIK MICHAEL E SVP & General Counsel
Sold, plan not stated
$842.09K 6,228 at 135.21
13.7%
28 Feb 2022
PREVOZNIK MICHAEL E SVP & General Counsel
Sold, plan not stated
$85.93K 661 at 130.00
1.7%
24 Feb 2022
Doherty Catherine T. SVP, Group Exec. Clin. Fran.
Sold, plan not stated
$347.22K 2,750 at 126.26
4.1%
24 Feb 2022
PREVOZNIK MICHAEL E SVP & General Counsel
Sold, plan not stated
$210.73K 1,669 at 126.26
4.3%
29 Nov 2021
Doherty Catherine T. SVP, Group Exec. Clin. Fran.
Sold, plan not stated 5×
$5.89M 37,565 at 156.81
35.3%
29 Jul 2021
RUSCKOWSKI STEPHEN H Chairman, CEO and President
Sold, plan not stated 2×
$1.34M 9,493 at 140.87
3.2%
28 Jul 2021
RUSCKOWSKI STEPHEN H Chairman, CEO and President
Sold, plan not stated
$19.58M 139,751 at 140.14
32.9%
27 Jul 2021
RUSCKOWSKI STEPHEN H Chairman, CEO and President
Sold, plan not stated
$4.59M 32,788 at 140.01
10.3%
27 Jul 2021
WILENSKY GAIL R Director
Sold, plan not stated 2×
$1.70M 12,222 at 139.30
40.6%
26 Jul 2021
RUSCKOWSKI STEPHEN H Chairman, CEO and President
Sold, plan not stated
$813.99K 5,813 at 140.03
2.0%
7 May 2021
Doherty Catherine T. SVP, Group Exec. Clin. Fran.
Sold, plan not stated
$1.19M 8,536 at 139.96
11.0%
5 May 2021
PREVOZNIK MICHAEL E SVP & General Counsel
Sold, plan not stated
$6.16M 44,939 at 137.00
52.8%
Sold half or more
10 Mar 2021
PREVOZNIK MICHAEL E SVP & General Counsel
Sold, plan not stated
$671.50K 5,574 at 120.47
12.2%
25 Feb 2021
PREVOZNIK MICHAEL E SVP & General Counsel
Sold, plan not stated
$92.51K 801 at 115.49
2.0%
24 Feb 2021
PREVOZNIK MICHAEL E SVP & General Counsel
Sold, plan not stated 2×
$138.94K 1,188 at 116.95
2.8%
24 Dec 2020
GUINAN MARK Executive Vice President & CFO
Sold, plan not stated 2×
$9.84M 81,756 at 120.37
52.6%
Sold half or more
24 Nov 2020
WILENSKY GAIL R Director
Sold, plan not stated
$770.12K 6,111 at 126.02
27.0%
23 Nov 2020
STANZIONE DANIEL Director
Sold, plan not stated 3×
$1.42M 11,223 at 126.30
28.4%
21 Oct 2020
Deppe Michael J VP, Corp. Controller & CAO
Sold, plan not stated 2×
$1.31M 10,450 at 125.00
29.4%
16 Oct 2020
RUSCKOWSKI STEPHEN H Chairman, CEO and President
Sold, plan not stated
$35.04M 291,997 at 120.00
55.1%
Sold half or more
14 Oct 2020
PREVOZNIK MICHAEL E SVP & General Counsel
Sold, plan not stated
$4.24M 35,591 at 119.00
47.0%
2 Sep 2020
Doherty Catherine T. SVP, Group Exec. Clin. Fran.
Sold, plan not stated 2×
$6.46M 58,392 at 110.60
46.0%
8 Jun 2020
GUINAN MARK Executive Vice President & CFO
Sold, plan not stated 3×
$8.51M 72,596 at 117.23
49.7%
8 Jun 2020
RING TIMOTHY M Director
Sold, plan not stated
$1.37M 11,730 at 116.60
36.4%
27 Apr 2020
RUSCKOWSKI STEPHEN H Chairman, CEO and President
Sold, plan not stated
$1.31M 11,717 at 112.01
4.7%
27 Apr 2020
EGLINTON MANNER CARRIE SVP, Advanced Diagnostics
Sold, plan not stated 2×
$555.08K 5,000 at 111.02
18.3%
16 Mar 2020
Davis J. E. EVP, General Diagnostics
Sold, plan not stated 5×
$308.25K 3,513 at 87.75
8.4%
11 Mar 2020
Doherty Catherine T. SVP, Group Exec. Clin. Fran.
Sold, plan not stated
$260.73K 2,501 at 104.25
3.5%
11 Mar 2020
PREVOZNIK MICHAEL E SVP & General Counsel
Sold, plan not stated
$226.74K 2,175 at 104.25
5.1%
10 Mar 2020
RUSCKOWSKI STEPHEN H Chairman, CEO and President
Sold, plan not stated
$11.22K 100 at 112.19
0.0%
6 Mar 2020
RUSCKOWSKI STEPHEN H Chairman, CEO and President
Sold, plan not stated 5×
$25.93M 230,178 at 112.67
50.4%
Sold half or more
Showing 1–50 of 121. Page 1 of 3 Older →